|
Loading...
Loading...
|
US Pharm. 2009;34(9):8.
Bethesda, MD -- The National Institute of Allergy and Infectious Diseases (NIAID) announced that an independent safety-monitoring committee has recommended that trials of a candidate 2009 H1N1 vaccine begin in children. Vaccinations will begin in two trials being conducted through NIAID's nationwide network of Vaccine and Treatment Evaluation Units (VTEU). The monitoring committee reviewed data from more than 500 healthy adult volunteers enrolled in three VTEU trials of candidate H1N1 vaccines that began on August 7, 2009, and found no safety concerns that would preclude trials in children.
|
Loading...
Loading...
|
|
U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date,
authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings,
including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations,
long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students,
other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn
Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE)
as a provider of continuing pharmacy education.
Copyright © 2000 - 2013 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.
|